The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy.

Jean-Baptiste ReisqsAdrien MoreauAzzouz CharrabiYvonne SleimanAlbano C MeliGilles MillatVeronique BriandPhilippe BeauvergerSylvain RichardPhilippe Chevalier

Published in: Clinical and translational medicine (2022)

Keyphrases

heart failure
human health
insulin resistance
catheter ablation
type diabetes
metabolic syndrome
atrial fibrillation